CannTrust Sales Grow 105% to $12.6 Million in Q3

CannTrust™ Reports Record Revenue for Q3 2018 and is Taking Steps to List on the New York Stock Exchange

VAUGHAN, ON, Nov. 14, 2018 /PRNewswire/ – CannTrust Holdings Inc. (“CannTrust” or the “Company” |TSX: TRST), a licensed producer of medical and recreational cannabis under the Cannabis Act and its regulations, today announced financial and operating results for the three and nine months ending September 30, 2018. All amounts expressed are in Canadian dollars.

Revenue for the three and nine month periods ended September 30, 2018 was $12,588,727 and $29,478,813 respectively, compared to $6,140,224 and $13,714,847 in the comparable 2017 periods. Net Income for the three and nine month periods ended September 30, 2018 was $421,240 and $11,968,255 respectively, compared to a net income of $655,309 and $632,269 in the comparable 2017 periods. Earnings per share for the three and nine month periods ended September 30, 2018 was $Nil and $0.12 respectively, compared to earnings per share of $0.01 and $0.01 in the comparable 2017 periods.

2018 Third Quarter Highlights Record revenues of $12.6M in Q3 2018, a 105% increase from the comparable prior year period

Operations for the quarter resulted in positive EBITDA and positive net income

Active patients increased to more than 50,000, a 61% increase from the comparable prior year period

Entered into supply agreements with 9 Canadian provinces to supply recreational cannabis across Canada Launched a fourth recreational brand: Peak Leaf Made our first shipment of cannabis oil to Denmark – the only cannabis oil accepted in […]

Click here to view full story at www.newcannabisventures.com